Batch- and Continuous-Flow Aerobic Oxidation of 14-Hydroxy Opioids to 1,3-Oxazolidines-A Concise Synthesis of Noroxymorphone.
暂无分享,去创建一个
Bernhard Gutmann | Ulrich Weigl | C. Kappe | C Oliver Kappe | D Phillip Cox | Bernhard Gutmann | U. Weigl | D. Cox
[1] T. Hudlický,et al. Unexpected N‐Demethylation of Oxymorphone and Oxycodone N‐Oxides Mediated by the Burgess Reagent: Direct Synthesis of Naltrexone, Naloxone, and Other Antagonists from Oxymorphone , 2012 .
[2] Richard J Ingham,et al. Organic synthesis: march of the machines. , 2015, Angewandte Chemie.
[3] C. Kappe,et al. Aerobic Oxidations in Continuous Flow , 2015 .
[4] J. G. Vries. A unifying mechanism for all high-temperature Heck reactions. The role of palladium colloids and anionic species , 2006 .
[5] M. Sainsbury,et al. An improved synthesis of noroxymorphone , 1992 .
[6] M. Hearn,et al. Studies on the oxidative N-demethylation of atropine, thebaine and oxycodone using a FeIII-TAML catalyst , 2014 .
[7] J. G. Vries,et al. Why Does Industry Not Use Immobilized Transition Metal Complexes as Catalysts , 2016 .
[8] J. Muzart. On the behavior of amines in the presence of Pd0 and PdII species , 2009 .
[9] M. Hearn,et al. One-pot oxidative N-demethylation of tropane alkaloids with hydrogen peroxide and a FeIII-TAML catalyst , 2012 .
[10] Steven V. Ley,et al. Organische Synthese: Vormarsch der Maschinen , 2015 .
[11] L. Watkins,et al. Structure-Activity Relationships of (+)-Naltrexone-Inspired Toll-like Receptor 4 (TLR4) Antagonists. , 2015, Journal of medicinal chemistry.
[12] S. Murahashi. Synthetic Aspects of Metal‐Catalyzed Oxidations of Amines and Related Reactions , 1995 .
[13] M. Manoharan,et al. Aromatic transition states in nonpericyclic reactions: anionic 5-endo cyclizations are aborted sigmatropic shifts. , 2012, Journal of the American Chemical Society.
[14] David Cantillo,et al. Continuous-flow technology—a tool for the safe manufacturing of active pharmaceutical ingredients. , 2015, Angewandte Chemie.
[15] M. Sadove,et al. Study of a narcotic antagonist--N-allyl-noroxymorphone. , 1963, JAMA.
[16] T. Hudlický,et al. Direct Synthesis of Naltrexone by Palladium-Catalyzed N-Demethylation/Acylation of Oxymorphone: The Benefit of CH Activation and the Intramolecular Acyl Transfer from C-14 Hydroxy , 2012 .
[17] J. Marton,et al. Synthesis of N-Substituted 7-Diprenorphine Derivatives , 1995 .
[18] S. Hosztafi,et al. Synthesis of N-Demethyl-N-Substituted Dihydroisomorphine and Dihydroisocodeine Derivatives+ , 1992 .
[19] T. Hosokawa,et al. Palladium(II)-catalyzed asymmetric oxidative cyclization of 2-allylphenols in the presence of copper(II) acetate and molecular oxygen. Study of the catalysis of the Wacker-type oxidation , 1981 .
[20] Zhiping Li,et al. Amide bond formation through iron-catalyzed oxidative amidation of tertiary amines with anhydrides. , 2013, The Journal of organic chemistry.
[21] M. Okimoto,et al. Electrooxidative Cyclization of Hydroxyamino Compounds Possessing a Benzyl Group , 2012 .
[22] A. Potthast,et al. A general, selective, high-yield N-demethylation procedure for tertiary amines by solid reagents in a convenient column chromatography-like setup. , 2004, Organic letters.
[23] C. Wiles,et al. Continuous process technology: a tool for sustainable production , 2014 .
[24] S. Hosztafi,et al. Synthesis of New Morphine Derivatives Containing Halogen in the Aromatic Ring , 1994 .
[25] T. Hudlický,et al. Palladium‐Catalyzed N‐Demethylation/N‐Acylation of Some Morphine and Tropane Alkaloids , 2008 .
[26] Ryan L. Hartman. Managing Solids in Microreactors for the Upstream Continuous Processing of Fine Chemicals , 2012 .
[27] D J Crouch,et al. Validation of twelve chemical spot tests for the detection of drugs of abuse. , 2000, Forensic science international.
[28] V. Cherkasov,et al. Interaction of 3,5-di-tert-butyl-o-benzoquinone with secondary amines—a pathway to new sterically hindered N,N-disubstituted o-aminophenols , 2011 .
[29] S. Murahashi. Synthetische Aspekte metallkatalysierter Oxidationen von Aminen und verwandte Reaktionen , 1995 .
[30] J. Iqbal,et al. Recent advances in transition metal catalyzed oxidation of organic substrates with molecular oxygen. , 2005, Chemical reviews.
[31] R. Luque,et al. Liquid phase oxidation chemistry in continuous-flow microreactors. , 2016, Chemical Society reviews.
[32] N. Jiao,et al. Recent advances in transition-metal catalyzed reactions using molecular oxygen as the oxidant. , 2012, Chemical Society reviews.
[33] G. Kok,et al. An Improved Process for the N-Demethylation of Opiate Alkaloids using an Iron(II) Catalyst in Acetate Buffer , 2009 .
[34] T. Hosokawa,et al. New aspects of oxypalladation of alkenes , 1990 .
[35] K. Rice,et al. Synthesis and biological activity of 8beta-substituted hydrocodone indole and hydromorphone indole derivatives. , 2002, Bioorganic & medicinal chemistry letters.
[36] P. Scammells,et al. New methodology for the N-demethylation of opiate alkaloids. , 2007, The Journal of organic chemistry.
[37] D. Oslin,et al. The Status of Naltrexone in the Treatment of Alcohol Dependence: Specific Effects on Heavy Drinking , 2006, Journal of clinical psychopharmacology.
[38] T. Hudlický,et al. General Method of Synthesis for Naloxone, Naltrexone, Nalbuphone, and Nalbuphine by the Reaction of Grignard Reagents with an Oxazolidine Derived from Oxymorphone , 2013 .
[39] S. Murahashi,et al. Palladium catalyzed amine exchange reaction of tertiary amines. Insertion of palladium(0) into carbon-hydrogen bonds , 1978 .
[40] K. Janda,et al. Unexpected 1,3-oxazolidine formation in the attempted oxidation of N-aryl-N-methyl substituted β-amino alcohols using pyridinium dichromate , 1998 .
[41] B. Gutmann,et al. Kontinuierliche Durchflussverfahren: ein Werkzeug für die sichere Synthese von pharmazeutischen Wirkstoffen , 2015 .
[42] T. Hudlický,et al. Improved Synthesis of Buprenorphine from Thebaine and/or Oripavine via Palladium‐Catalyzed N‐Demethylation/Acylation and/or Concomitant O‐Demethylation , 2012 .
[43] E. Zvartau,et al. A highly selective kappa-opioid receptor agonist with low addictive potential and dependence liability. , 2006, Bioorganic & medicinal chemistry letters.